Related Experiment Video
Updated: Jan 30, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
NEMO: cancer subtyping by integration of partial multi-omic data
Nimrod Rappoport1, Ron Shamir1
1Blavatnik School of Computer Science, Tel Aviv University, Tel Aviv, Israel.
NEMO, a novel multi-omics clustering algorithm, effectively defines cancer subtypes using incomplete patient data. This approach improves upon existing methods, offering a faster and simpler solution for cancer subtyping and personalized treatment strategies.
Area of Science:
- Computational biology
- Cancer genomics
- Bioinformatics
Background:
- Cancer subtypes are traditionally defined using single omic data.
- Multi-omic data offers a more comprehensive view for defining cancer subtypes.
- Accurate cancer subtyping can lead to more precise patient treatments.
Purpose of the Study:
- To introduce NEMO, a novel algorithm for multi-omics clustering.
- To enable cancer subtyping using partial multi-omic datasets without imputation.
- To evaluate NEMO's performance against state-of-the-art methods.
Main Methods:
- NEMO (NEighborhood based Multi-Omics clustering) algorithm development.
- Application of NEMO to ten cancer datasets (3168 patients).
- Comparison of NEMO with nine existing multi-omics clustering algorithms on full and partial data.
Main Results:
- NEMO achieved comparable results to state-of-the-art algorithms on full multi-omic data.
- NEMO demonstrated improved performance on partial multi-omic datasets.
- NEMO analysis of AML patient data highlighted its utility.
Conclusions:
- NEMO is an efficient and simple multi-omics clustering algorithm.
- NEMO effectively handles partial datasets, advancing cancer subtyping.
- The algorithm facilitates a deeper understanding of cancer biology and personalized medicine.
More Related Videos
Related Concept Videos
Integration of Rational Functions Using Partial Fractions
Partial Fractions
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Integration by Parts: Indefinite Integrals

